Short Interest in Crescent Capital BDC, Inc. (NASDAQ:CCAP) Expands By 32.9%

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 131,700 shares, an increase of 32.9% from the March 15th total of 99,100 shares. Based on an average daily trading volume, of 94,900 shares, the short-interest ratio is presently 1.4 days.

Crescent Capital BDC Price Performance

CCAP traded down $0.15 during trading hours on Friday, hitting $16.96. The company's stock had a trading volume of 82,371 shares, compared to its average volume of 99,214. The business's 50-day moving average price is $16.87 and its 200-day moving average price is $16.76. Crescent Capital BDC has a 12 month low of $13.11 and a 12 month high of $18.00. The stock has a market cap of $628.54 million, a price-to-earnings ratio of 7.41 and a beta of 0.83. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.14.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last announced its quarterly earnings results on Wednesday, February 21st. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.57 by $0.04. Crescent Capital BDC had a net margin of 45.54% and a return on equity of 11.32%. The company had revenue of $50.00 million for the quarter, compared to analysts' expectations of $47.99 million. Sell-side analysts expect that Crescent Capital BDC will post 2.26 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, April 15th. Investors of record on Friday, March 29th will be given a $0.41 dividend. This represents a $1.64 annualized dividend and a yield of 9.67%. The ex-dividend date of this dividend is Wednesday, March 27th. Crescent Capital BDC's dividend payout ratio is presently 71.62%.

Institutional Investors Weigh In On Crescent Capital BDC

Several large investors have recently bought and sold shares of CCAP. Tower Research Capital LLC TRC boosted its stake in Crescent Capital BDC by 393.6% during the first quarter. Tower Research Capital LLC TRC now owns 3,391 shares of the company's stock worth $46,000 after buying an additional 2,704 shares during the period. Cape Investment Advisory Inc. purchased a new position in Crescent Capital BDC during the fourth quarter worth $63,000. UBS Group AG boosted its stake in Crescent Capital BDC by 48.2% during the first quarter. UBS Group AG now owns 6,645 shares of the company's stock worth $118,000 after buying an additional 2,160 shares during the period. Qube Research & Technologies Ltd purchased a new position in Crescent Capital BDC during the third quarter worth $142,000. Finally, Cubist Systematic Strategies LLC purchased a new position in Crescent Capital BDC during the first quarter worth $144,000. Institutional investors own 49.46% of the company's stock.

Analyst Ratings Changes

CCAP has been the topic of several recent analyst reports. Oppenheimer lifted their price objective on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the company an "outperform" rating in a research report on Friday, February 23rd. Wells Fargo & Company lifted their price objective on shares of Crescent Capital BDC from $16.00 to $16.50 and gave the company an "equal weight" rating in a research report on Monday, January 29th.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.